Ergoteles’s TriSalus Life Sciences TLSI Stock Holding History

Ergoteles’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-38,940	Closed	-$387K	–	1882
2022 Q3	$387K	Hold	38,940	–	–	0.01%	866
2022 Q2	$383K	Hold	38,940	–	–	0.01%	979
2022 Q1	$382K	Buy	+38,940	New	+$384K	0.01%	767

Other funds holding TLSI

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

DFCM

Dark Forest Capital Management San Juan, Puerto Rico $1.13B AUM 18.74% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ergoteles's TLSI Position: Q4 2022 in Review

Ergoteles sold out of TriSalus Life Sciences (TLSI) in Q4 2022, closing a stake of 38,940 shares — an estimated $387K sold.

Ergoteles first reported a position in TLSI in Q1 2022 and held it in 3 quarters. The position peaked at $387K in Q3 2022. 9 funds tracked by Wall St. Rank hold TLSI as of Q4 2022.

Ergoteles reported no remaining TriSalus Life Sciences position as of Q4 2022 after selling out during the quarter.
Ergoteles sold 38,940 TriSalus Life Sciences shares in Q4 2022, an estimated $387K.
Ergoteles first reported a position in TriSalus Life Sciences in Q1 2022 and held it in 3 quarters.
Ergoteles's TriSalus Life Sciences position peaked at $387K in Q3 2022.
9 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.